Edx Medical Group (LON:EDX – Get Free Report) insider Christopher Evans bought 197,500 shares of the company’s stock in a transaction on Friday, November 6th. The stock was bought at an average price of GBX 8 per share, for a total transaction of £15,800.
Edx Medical Group Stock Performance
Shares of Edx Medical Group stock traded up GBX 0.10 on Monday, hitting GBX 7.50. 237,845 shares of the company traded hands, compared to its average volume of 74,193. The company has a 50 day moving average of GBX 8.71. Edx Medical Group has a 52 week low of GBX 6 and a 52 week high of GBX 13. The stock has a market cap of £32.35 million and a P/E ratio of -5.04.
Edx Medical Group (LON:EDX – Get Free Report) last announced its quarterly earnings results on Thursday, September 3rd. The company reported GBX (1.50) earnings per share (EPS) for the quarter.
About Edx Medical Group
EDX Medical Group plc is a United Kingdom-based medical diagnostics company focused on developing and commercializing clinical tests intended to support the detection, diagnosis and management of disease. Its work is centered on molecular and genetic testing, with an emphasis on providing more personalized information to healthcare professionals and patients.
The company’s activities include the development of diagnostic and screening products for applications such as cancer and other significant health conditions.
Featured Stories
- Five stocks we like better than Edx Medical Group
- Want to Escape the AI Sell-Off? This ETF Offers a Surprising Alternative
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
Receive News & Ratings for Edx Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edx Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
